SCHEMBL6030159

SCHEMBL6030159

COC(=O)c1sccc1S(=O)(=O)N1CCc2cc(OC)cc(OC)c2C1c1cccc(OC(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.39
TAS2R14 Q9NYV8 2/20 0.38
FKBP1A P62942 2/20 0.38
MAPT P10636 3/20 0.37
TP53 P04637 1/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
THRB P10828 1/20 0.36
GRIN2C Q14957 3/20 0.36
USP2 O75604 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HCRTR2 O43614 2/20 0.35
HCRTR1 O43613 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4417162 0.85 SMN1; SMN2 (0.43) NPSR1L3MBTL1TAS2R14FKBP1AMAPT
SCHEMBL4412007 0.84 MAPT (0.46) LMNAFKBP1AMAPTTP53PPARG
SCHEMBL13972857 0.83 TAS2R14 (0.49) NPSR1L3MBTL1LMNATAS2R14FKBP1A
SCHEMBL4552332 0.83 TAS2R14 (0.49) NPSR1L3MBTL1LMNATAS2R14FKBP1A
SCHEMBL4423028 0.82 CA1 (0.41) NPSR1L3MBTL1LMNATAS2R14MAPT
SCHEMBL13973317 0.82 CA1 (0.41) NPSR1L3MBTL1LMNATAS2R14MAPT
SCHEMBL4422262 0.82 NPSR1 (0.40) NPSR1L3MBTL1LMNATAS2R14FKBP1A
SCHEMBL4415190 0.82 CA1 (0.41) NPSR1L3MBTL1TAS2R14FKBP1AGRIN2C
SCHEMBL4410698 0.80 NPSR1 (0.41) NPSR1L3MBTL1LMNATAS2R14FKBP1A
SCHEMBL4422266 0.79 HTR6 (0.40) NPSR1L3MBTL1TAS2R14FKBP1AGRIN2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663983-B1 N-SUBSTITUTED, 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2009-01-21 EP disclosed
EP-1663983-A1 N-SUBSTITUTED, 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2006-06-07 EP disclosed
US-20050070570-A1 Novel potassium channels modulators 4SC AG (DE) 2005-03-31 US disclosed
WO-2004113302-A1 N-SUBSTITUTED 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2004-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070570-A1 Novel potassium channels modulators HCN4, KCNA4, KCNN4 NPSR1 155/4885L3MBTL1 2533/4885LMNA 4519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.